News
Bormioli Pharma launches the 3rd edition of its ESG Report, reaching the 45% of sustainable materials in sold products with its EcoPositive range
Bormioli Pharma, an international leader in pharmaceutical packaging and medical devices, announced the third edition of its Sustainability Report.
This edition outlines and consolidates the strong progress Bormioli Pharma has made in promoting sustainable growth in the communities where the...
News
The Future of Healthcare: Interoperability and the Patient Experience
Fragmentation in healthcare data is a stark reality today. Many patients' medical records lie dispersed among several filing cabinets, each originating from a separate physician's office, hospital, or laboratory. Such fragmentation of medical records into discrete systems often breeds...
Drug Research
EMA Offers Plans To Enhance Availability of Vital Medicines
As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical medicines and go on to formally launch the Critical Medicines Alliance, the European Medicines Agency-...
News
Schreiner MediPharm Introduces Late-Stage Customization Service for Its RFID-Labels
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced late-stage customization capabilities for its RFID-Labels series. The new service offering enables the company’s smart labels to be supplied on short notice...
News
Ardena’s Nanomedicines Facility Marks €20 Million Expansion with first GMP approval
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility.
The facility includes...
News
Cell & Gene Therapies: FDA Regulatory Considerations In 2024
The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products by the FDA’s Center for Biologics Research and Evaluation- BER and need approval of a...
Clinical Trials
Can Clinical Research Spectrum Make The Most of Gene Therapy
It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first approval when it comes to gene therapy in 2017, oncology researchers have gone on to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read